SciSparc Announces Collaboration with Clearmind Medicine Inc.
TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: CMND) (FSE: CWY), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems.
Publication of Patent Application
Clearmind has announced the publication of its patent application under the international Patent Cooperation Treaty, for innovative combinations of ketamine and N-acylethanolamines. This breakthrough in psychedelic-derived therapeutics could potentially revolutionize the treatment of mental health disorders that have been historically under-treated.
Impact on Individuals
For individuals struggling with mental health issues, this collaboration between SciSparc and Clearmind could offer new hope for effective treatment options. The innovative combinations of ketamine and N-acylethanolamines could provide relief for those suffering from conditions such as depression, anxiety, and PTSD.
Global Impact
On a larger scale, the development of novel psychedelic-derived therapeutics could have a significant impact on the world’s approach to mental health treatment. By addressing major under-treated mental health problems, this collaboration has the potential to improve the quality of life for millions of people around the globe.
Conclusion
The collaboration between SciSparc and Clearmind represents a major step forward in the field of mental health therapeutics. By combining expertise in pharmaceutical development and psychedelic-derived treatments, these companies are paving the way for innovative solutions that could change the lives of individuals and make a positive impact on a global scale.
